PMVP FY 2022 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$650,000

Operating Income

-$77M

Net Income

-$73M

EPS (Diluted)

$-1.61

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$72M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$270M

Total Liabilities

$24M

Stockholders' Equity

$246M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$650,000	-$1M	+49.3%
Operating Income	-$77M	-$58M	-32.2%
Net Income	-$73M	-$58M	-26.7%